about
Inactivation of the acid labile subunit gene in mice results in mild retardation of postnatal growth despite profound disruptions in the circulating insulin-like growth factor systemEndothelial cells and the IGF systemThe N-terminal subdomain of insulin-like growth factor (IGF) binding protein 6. Structure and interaction with IGFsThe N-terminal disulfide linkages of human insulin-like growth factor-binding protein-6 (hIGFBP-6) and hIGFBP-1 are different as determined by mass spectrometryStructure, dynamics and heparin binding of the C-terminal domain of insulin-like growth factor-binding protein-2 (IGFBP-2)Measurement of insulin-like growth factor (IGF)-II binding to purified IGF binding proteins 1-6: comparison of charcoal adsorption and high performance size exclusion chromatographyInhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathwayO-glycosylation of insulin-like growth factor (IGF) binding protein-6 maintains high IGF-II binding affinity by decreasing binding to glycosaminoglycans and susceptibility to proteolysisC-terminal domain of insulin-like growth factor (IGF) binding protein-6: structure and interaction with IGF-IIInhibition of Plasmodium falciparum CDPK1 by conditional expression of its J-domain demonstrates a key role in schizont developmentInsulin-like growth factor binding proteins 4-6.Association of a nicotinic receptor mutation with reduced height and blunted physostigmine-stimulated growth hormone release.Differential Effects of Insulin-Like Growth Factor Binding Protein-6 (IGFBP-6) on Migration of Two Ovarian Cancer Cell LinesRecent insights into the actions of IGFBP-6.IGFBP-6 five years on; not so 'forgotten'?IGF-binding proteins--the pieces are falling into place.Prohibitin-2 binding modulates insulin-like growth factor-binding protein-6 (IGFBP-6)-induced rhabdomyosarcoma cell migration.Recombinant human thyroid-stimulating hormone (Thyrogen) in thyroid cancer follow up: experience at a single institution.The insulin-like growth factor system in kidney disease and hypertension.Insulin-like growth factor-binding protein-6 and cancer.Insulin-like growth factors and kidney disease.Cooperativity of the N- and C-terminal domains of insulin-like growth factor (IGF) binding protein 2 in IGF binding.Fibroblast growth factor-2 over-rides insulin-like growth factor-I induced proliferation and cell survival in human neuroblastoma cells.Ezrin contributes to impaired podocyte migration and adhesion caused by advanced glycation end products.Papillary thyroid cancer-derived exosomes contain miRNA-146b and miRNA-222.The high burden of inpatient diabetes mellitus: the Melbourne Public Hospitals Diabetes Inpatient Audit.Cross-talk between MAP kinase pathways is involved in IGF-independent, IGFBP-6-induced Rh30 rhabdomyosarcoma cell migration.Insulin-like growth factors induce apoptosis as well as proliferation in LIM 1215 colon cancer cells.Insulin-like growth factor binding protein-6 and CCI-779, an ester analogue of rapamycin, additively inhibit rhabdomyosarcoma growth.Advanced glycation end products inhibit tubulogenesis and migration of kidney epithelial cells in an ezrin-dependent manner.Preservation of kidney function with combined inhibition of NADPH oxidase and angiotensin-converting enzyme in diabetic nephropathy.Prevalence and predictors of diabetes after lung transplantation: a prospective, longitudinal study.The amino-terminal domains of the ezrin, radixin, and moesin (ERM) proteins bind advanced glycation end products, an interaction that may play a role in the development of diabetic complications.Urokinase type plasminogen activator receptor is involved in insulin-like growth factor-induced migration of rhabdomyosarcoma cells in vitro.Targeting the AGE-RAGE axis improves renal function in the context of a healthy diet low in advanced glycation end-product content.Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-alpha-dependent pathway.Expression of the IGF system in normal and diabetic transgenic (mRen-2)27 rat eye.A case of mucormycosis limited to the parotid gland.Contributions of the N- and C-terminal domains of IGF binding protein-6 to IGF binding.Uptake of advanced glycation end products by proximal tubule epithelial cells via macropinocytosis.
P50
Q24681712-47A68A5C-B328-4E39-B4AF-5DB219D5231DQ26826908-9BB570EE-C49E-4BCB-9663-BA75E6D60AF9Q27643837-5C363350-F5CC-40F1-B78C-C2438C06E8B2Q28144118-04E38B86-238E-4F8C-80B3-FCB56E7288F0Q28266958-2691B9D2-5A83-488B-8109-4273946F9496Q28288303-74D72AD8-7087-44D7-846B-AA82FAC2B8C3Q28571271-366D9B5B-0DE6-4798-AC43-5FC10105E8E7Q28616606-6BF39A26-F8BF-4299-AD98-0954AFB6D5E3Q28910460-D708C913-4BEB-40E6-98D0-E34C75E2D330Q30042400-DB212C0D-17B8-4512-96E4-4365A28AEDBAQ30380932-308F771B-6E22-4BAA-AE42-B422B18A2D3DQ34718761-54B15135-5F87-4C41-8194-E5BC05CA3D0AQ34818399-DE983E32-F76A-4C63-94F7-7178F2EB1BF4Q35690623-340F465A-966D-41DB-9DB4-23595597F664Q36137788-B9D6258D-9647-400B-9A13-39D1D36D50EBQ36151482-0515499F-03C2-4BDE-B286-9F50E5534E5DQ37226250-811C8F4F-1EE8-4148-B2A3-8424CECBC2F8Q37453658-ADDAA229-1E6A-4680-897A-2AFFC298490EQ37962116-2FA66A31-DCDE-4848-BBEA-CC591BEA2FEBQ38057775-9656E0A8-1ECC-4333-9401-CAB667759B29Q38242675-D7327FED-DD2B-49A9-B49C-5F0E6CAED2F8Q38296639-67300B87-85F6-44D9-A7EA-B9D8D502B951Q38342262-AEA8C825-3F08-46A4-8B15-5AD53E7FA1B8Q38868777-756160A1-C059-4180-9224-E8060537CC28Q38893636-DE64B7CE-8E65-4DA8-B50D-0C7B673B7B47Q39129039-77AE464B-5323-4232-8128-5BF1A83C12FEQ39708906-7A7BE5C7-DE36-401E-981F-D775BB39D720Q40247512-C5C8907B-B099-41F3-92C8-0F43FB9D287EQ40601493-1AF9F38C-A278-442E-B1DD-E90599DCECDFQ42488313-4BBBED07-A5AE-4AA4-A6B6-D8B6D462A234Q43020318-C0720CE9-3D00-4D55-8101-EFBB7383B2B8Q44320779-8C1402FA-B1DD-473A-B04B-9687129DE3E7Q44432075-87025637-0781-47BE-A287-E952BE1FFF00Q44564580-FFEA0D79-2529-41FC-A34F-566D5804369EQ44633271-0DA9E0D2-A69E-4718-A023-CEF1DB4B6FACQ45124408-3E75E045-AC94-4AF8-9E61-65FF879BB152Q46618762-A33A59F7-972C-4656-881C-AF1712C7E617Q46766683-6AAD4D02-8277-4F91-8388-656A5083ABA2Q50336335-17835728-59E4-4EBB-99CD-034A02C9754FQ50926276-E82D05D4-F926-4D16-980A-22243FCBD92F
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Leon A Bach
@nl
Leon A Bach
@sl
Leon A. Bach
@en
Leon A. Bach
@es
type
label
Leon A Bach
@nl
Leon A Bach
@sl
Leon A. Bach
@en
Leon A. Bach
@es
prefLabel
Leon A Bach
@nl
Leon A Bach
@sl
Leon A. Bach
@en
Leon A. Bach
@es
P106
P1153
7006699734
P21
P31
P496
0000-0002-9062-1518